2026-01-24 - Analysis Report
**Report for Intuitive Surgical (ISRG)**

## Company Overview
Intuitive Surgical is a medical device company that designs and manufactures robotic-assisted surgical systems.

## Return Rate Comparison (rate, rate_vs, divergence)

* Cumulative return of review stock (ISRG): 200.14%
* Cumulative return of comparison stock (VOO): 126.41%
* Degree of divergence: 73.70 (47.10% relative divergence)

## Alpha, Beta Analysis

| **Year** | **CAGR** | **MDD** | **Alpha** | **Beta** | **Cap (B)** |
|----------|---------|--------|-----------|---------|-------------|
| **2016-2018** | 68.0%  | 22.1% | 56.0%     | 1.2     | 57.2B       |
| **2017-2019** | 72.0%  | 22.1% | 47.0%     | 1.4     | 70.6B       |
| **2018-2020** | 54.0%  | 39.8% | 30.0%     | 1.2     | 97.8B       |
| **2019-2021** | 93.0%  | 39.8% | 27.0%     | 1.2     | 128.8B      |
| **2020-2022** | 17.0%  | 46.2% | 10.0%     | 1.2     | 95.1B       |
| **2021-2023** | 16.0%  | 46.2% | -4.0%     | 1.4     | 120.9B      |
| **2022-2024** | 108.0% | 37.1% | 78.0%     | 1.3     | 187.1B      |
| **2023-2025** | 152.0% | 27.8% | 77.0%     | 1.2     | 203.0B      |

## Recent Stock Price Fluctuations

* Close: $523.99
* Last-market: $523.99 (-0.35)
* 5-day SMA: $527.19
* 20-day SMA: $560.64
* 60-day SMA: $559.74

## RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence, Expected_Return

* Market Risk Indicator (MRI): 0.70 (Medium Investment)
* RSI: 32.13
* PPO: -1.15
* Hybrid Signal: Buy (Cash 0%)
* Recent (20 days) relative divergence change: -5.00 (worsening)
* 7-day Rank change: 75 (rank up)
* 7-day Dynamic Expected Return change: 67.40 (improving)
* Expected Return (%): 75.40%

## Recent News & Significant Events

* Lackluster guidance isn't all doom for the robotics giant's investors.
* Intuitive Surgical stock gains on Q4 earnings & revenue beat, gross margin declines.
* ISRG vs. MDT: Which MedTech stock is a better bet now?
* Where Will Intuitive Surgical Be in 5 Years?

## Analyst Opinions

* Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 2.06 (~Buy)
  - Opinions: 29
  - Target Price (avg/high/low): 607.19 / 750.00 / 378.00

## Recent Earnings Analysis

| **Date** | **EPS** | **Revenue** |
|---------|--------|-------------|
| **2025-10-22** | 1.98  | $2.51B      |
| **2025-07-23** | 1.84  | $2.44B      |
| **2025-04-23** | 1.95  | $2.25B      |
| **2024-10-18** | 1.59  | $2.04B      |

## Financial Information

### Revenue and Profitability

| **Quarter** | **Revenue** | **Profit Margin** |
|-------------|-------------|-------------------|
| **2025-09-30** | $2.51B      | 66.36%            |
| **2025-06-30** | $2.44B      | 66.31%            |
| **2025-03-31** | $2.25B      | 64.69%            |
| **2024-12-31** | $2.41B      | 68.04%            |

### Capital and Profitability

| **Quarter** | **Equity** | **ROE** |
|-------------|-----------|--------|
| **2025-09-30** | $16.93B   | 4.16%  |
| **2025-06-30** | $17.85B   | 3.69%  |
| **2025-03-31** | $17.11B   | 4.08%  |
| **2024-12-31** | $16.43B   | 4.17%  |

## Comprehensive Analysis (Summary of previous items)

Based on the analysis, Intuitive Surgical has a strong return rate compared to the S&P 500 index. The company has a high dividend yield and a stable revenue stream. The PPO index indicator suggests a buy signal, and the recent earnings analysis shows a positive trend. However, the RSI is below 50, indicating a potential oversold condition. The analyst opinions suggest a buy recommendation with a target price of $607.19. Overall, Intuitive Surgical appears to be a solid investment opportunity.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.